|
|
Beth Am Women: Medical Marijuana |
It is obligatory from the Torah* for the physician to heal the sick (Maimonides commentary on Mishnah Nedarim 4:4) Maimonides listed health care as the most important communal service for a city to provide its residents (Mishneh Torah, Hilchot De'ot IV:23) ISSUE BACKGROUND Most frequently traumatic injury is caused by motor vehicle collisions, falls, fires, drowning, gun fire and assaults. In the United States, more than 150,000 people die from injuries, which are the primary cause of death and disability among children and young adults. Traumatic brain injuries and traumatic spinal cord injuries are the two most severe disabling injury conditions. Injury control policies involve prevention and trauma care. Prevention takes many forms, such as addressing domestic violence, promoting seat belt and child safety seat use and supporting children's safe sleepwear standards. Trauma care policies include the creation of regional burn and trauma care systems to treat the seriously injured, highly trained caregivers, advanced treatment technology and rapid communication and transportation to reach patients faster. In some parts of the country medical helicopters are available to carry burn and trauma patients to trauma centers where they can be most effectively treated. Studies of conventional trauma care show that as many as 35% of trauma care patient deaths could have been prevented if optimal acute care had been available. There is great need to expand burn and trauma center facilities and systems to areas not now covered. The use of marijuana as medicine goes back at least 5,000 years as a highly valued remedy. Under the Controlled Substances Act of 1970, U.S. law currently defines marijuana as a Schedule I drug - a prohibited substance - having no medical use and high potential for abuse. Schedule II drugs have restricted access as highly controlled medications that are prescribed in writing in triplicate using the physician's assigned number. Moreover, Schedule II medications are for use in pain management for a limited period of time in limited quantity. Anecdotally based reports on the medical use of marijuana have indicated that it provides relief from symptoms, conditions and treatment side effects of several serious illnesses. These include glaucoma, the wasting syndrome associated with AIDS, nausea associated with cancer chemotherapy, muscle spasms which often accompany multiple sclerosis and chronic pain. Thus far, scientific studies regarding the efficacy and safety of marijuana use for therapeutic purposes have been inconclusive. In recent years the development and implementation of pain management have changed. More than 30 states have approved legislation in support of the medicinal use of marijuana. Federal law supersedes state law, however, and prevents both the implementation of these states' mandates and further research on its therapeutic properties. Because marijuana is not legally available, patients must resort to the black market to obtain relief and are thus subject to arrest and incarceration. At this time the medical use of marijuana is not approved in any country of the world. Health Canada, the Canadian federal health agency, has proposed a research plan for the medical use of marijuana and anticipates that its research activities will inform the debate on the use of marijuana as a legitimate, alternative therapeutic option and the development of appropriate regulatory mechanisms. Moreover, in January 1997, the White House Office of National Drug Control Policy asked the Institute of Medicine to assess the potential health benefits and risks of marijuana and its cannabinoid compounds (the primary psychoactive ingredients). The Institute of Medicine's report released in March 1999, recommends continued research into physiological effects of marijuana's constituent cannabinoids and their potential therapeutic value for pain relief, including closely monitored clinical trials of smoked marijuana. The Institute of Medicine's report also recommends short term use (less than 6 months) of marijuana for patients with debilitating symptoms for whom all approved medications have failed and relief of symptoms could be reasonably expected, with treatment administered under medical supervision and the guidance of an institutional review board. RESOLUTION
In addition WRJ calls upon its North American Sisterhoods to:
*Torah is God's teaching to the Jewish people Visit the WRJ home page Copyright © 2000, Women of Reform Judaism
|
||
|
|
|||